​Join Nucleate San Diego and Twist Bioscience for State of AI × Biotech, a discussion on where AI is already creating tangible value across biotech R&D, where technical and translational barriers remain, and which applications are most likely to shape the field next.

​AI is moving rapidly from proof of concept toward integration across biotechnology, with generative models, biological foundation models, and AI-enabled discovery platforms beginning to influence how biological systems are understood, designed, and interrogated.

As the field moves toward real-world application, questions around validation, scalability, and translational impact are becoming increasingly important. These challenges are especially relevant at the intersection of AI and synthetic biology, where advances in biological engineering are expanding our capacity to build, test, and experimentally validate computationally designed systems.

This event opens the Nucleate Inside Series, a chapter-wide program exploring the major avenues through which AI is influencing biotechnology, including drug discovery, lab automation, cell and gene therapy, and clinical translation, alongside the fundamentals of venture creation and building a biotechnology company.